<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10</volume><submitter>Sun Y</submitter><pubmed_abstract>Congenital heart defects occur in almost 80% of patients with CHARGE syndrome, a sporadically occurring disease causing craniofacial and other abnormalities due to mutations in the &lt;i>CHD7&lt;/i> gene. Animal models have been generated to mimic CHARGE syndrome; however, heart defects are not extensively described in zebrafish disease models of CHARGE using morpholino injections or genetic mutants. Here, we describe the co-occurrence of craniofacial abnormalities and heart defects in zebrafish &lt;i>chd7&lt;/i> mutants. These mutant phenotypes are enhanced in the maternal zygotic mutant background. In the &lt;i>chd7&lt;/i> mutant fish, we found shortened craniofacial cartilages and extra cartilage formation. Furthermore, the length of the ventral aorta is altered in &lt;i>chd7&lt;/i> mutants. Many CHARGE patients have aortic arch anomalies. It should be noted that the aberrant branching of the first branchial arch artery is observed for the first time in &lt;i>chd7&lt;/i> fish mutants. To understand the cellular mechanism of CHARGE syndrome, neural crest cells (NCCs), that contribute to craniofacial and cardiovascular tissues, are examined using &lt;i>sox10:Cre&lt;/i> lineage tracing. In contrast to its function in cranial NCCs, we found that the cardiac NCC-derived mural cells along the ventral aorta and aortic arch arteries are not affected in &lt;i>chd7&lt;/i> mutant fish. The &lt;i>chd7&lt;/i> fish mutants we generated recapitulate some of the craniofacial and cardiovascular phenotypes found in CHARGE patients and can be used to further determine the roles of CHD7.</pubmed_abstract><journal>Frontiers in cell and developmental biology</journal><pagination>1030587</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9768498</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Craniofacial and cardiac defects in &lt;i>chd7&lt;/i> zebrafish mutants mimic CHARGE syndrome.</pubmed_title><pmcid>PMC9768498</pmcid><pubmed_authors>Tian Z</pubmed_authors><pubmed_authors>Kumar SR</pubmed_authors><pubmed_authors>Wong CED</pubmed_authors><pubmed_authors>Crump JG</pubmed_authors><pubmed_authors>Lien CL</pubmed_authors><pubmed_authors>Bajpai R</pubmed_authors><pubmed_authors>Sun Y</pubmed_authors><pubmed_authors>Bai H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Craniofacial and cardiac defects in &lt;i>chd7&lt;/i> zebrafish mutants mimic CHARGE syndrome.</name><description>Congenital heart defects occur in almost 80% of patients with CHARGE syndrome, a sporadically occurring disease causing craniofacial and other abnormalities due to mutations in the &lt;i>CHD7&lt;/i> gene. Animal models have been generated to mimic CHARGE syndrome; however, heart defects are not extensively described in zebrafish disease models of CHARGE using morpholino injections or genetic mutants. Here, we describe the co-occurrence of craniofacial abnormalities and heart defects in zebrafish &lt;i>chd7&lt;/i> mutants. These mutant phenotypes are enhanced in the maternal zygotic mutant background. In the &lt;i>chd7&lt;/i> mutant fish, we found shortened craniofacial cartilages and extra cartilage formation. Furthermore, the length of the ventral aorta is altered in &lt;i>chd7&lt;/i> mutants. Many CHARGE patients have aortic arch anomalies. It should be noted that the aberrant branching of the first branchial arch artery is observed for the first time in &lt;i>chd7&lt;/i> fish mutants. To understand the cellular mechanism of CHARGE syndrome, neural crest cells (NCCs), that contribute to craniofacial and cardiovascular tissues, are examined using &lt;i>sox10:Cre&lt;/i> lineage tracing. In contrast to its function in cranial NCCs, we found that the cardiac NCC-derived mural cells along the ventral aorta and aortic arch arteries are not affected in &lt;i>chd7&lt;/i> mutant fish. The &lt;i>chd7&lt;/i> fish mutants we generated recapitulate some of the craniofacial and cardiovascular phenotypes found in CHARGE patients and can be used to further determine the roles of CHD7.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-05T14:57:09.475Z</modification><creation>2025-04-05T14:57:09.475Z</creation></dates><accession>S-EPMC9768498</accession><cross_references><pubmed>36568983</pubmed><doi>10.3389/fcell.2022.1030587</doi></cross_references></HashMap>